Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 06 Mar 2023 for Sesen Bio, Inc., €115k. Read the official filing
Filing timeline
BuySaleThomas R. Cannell
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Thomas R. Cannell: trading record in brief
Thomas R. Cannell is a declared insider at 2 companies (chief executive); the most frequent names are Sesen Bio, Inc. and Orexigen Therapeutics, Inc. In total, 4 filings cover trades dated from 30 November 2015 to 2 March 2023.
Every open-market trade on record is a sale: 2 sales worth €144k. Besides market trades, the filings include 2 share grants. In 2023 alone, the filings show no purchases and 2 sales.
Most recently, on 6 March 2023, the filings show an open-market sale worth €115k in Sesen Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas R. Cannell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
208,923 shares@ US$0.58779.6% of flowCommon StockSEC:0001485003-23-000105:0
53,727 shares@ US$0.587320.4% of flowCommon StockSEC:0001485003-23-000062:0
606,800 shares0Common StockSEC:0001485003-22-000020:0
5,091 sharesCommon StockSEC:0001209191-16-095646:0
4 of 4 declarations
